Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 1
1990 6
1991 9
1992 4
1993 7
1994 15
1995 9
1996 13
1997 3
1998 12
1999 8
2000 5
2001 6
2002 3
2003 1
2005 4
2006 3
2007 2
2008 1
2010 1
2012 1
2013 1
2014 2
2016 1
2017 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 9569054

121 results

Results by year

Filters applied: . Clear all
Page 1
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
Bajetta E, Di Bartolomeo M, Carnaghi C, Buzzoni R, Mariani L, Gebbia V, Comella G, Pinotti G, Ianniello G, Schieppati G, Bochicchio AM, Maiorino L. Bajetta E, et al. Br J Cancer. 1998 Apr;77(7):1149-54. doi: 10.1038/bjc.1998.191. Br J Cancer. 1998. PMID: 9569054 Free PMC article. Clinical Trial.
A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients.
O'Shaughnessy JA, Denicoff AM, Venzon DJ, Danforth D, Pierce LJ, Frame JN, Bastian A, Ghosh B, Goldspiel B, Miller L, et al. O'Shaughnessy JA, et al. Ann Oncol. 1994 Oct;5(8):709-16. doi: 10.1093/oxfordjournals.annonc.a058975. Ann Oncol. 1994. PMID: 7826903 Free article. Clinical Trial.
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.
Pujol JL, Douillard JY, Rivière A, Quoix E, Lagrange JL, Berthaud P, Bardonnet-Comte M, Polin V, Gautier V, Milleron B, Chomy F, Chomy P, Spaeth D, Le Chevalier T. Pujol JL, et al. J Clin Oncol. 1997 May;15(5):2082-9. doi: 10.1200/JCO.1997.15.5.2082. J Clin Oncol. 1997. PMID: 9164221 Clinical Trial.
Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.
Bunn PA Jr, Crowley J, Kelly K, Hazuka MB, Beasley K, Upchurch C, Livingston R, Weiss GR, Hicks WJ, Gandara DR, et al. Bunn PA Jr, et al. J Clin Oncol. 1995 Jul;13(7):1632-41. doi: 10.1200/JCO.1995.13.7.1632. J Clin Oncol. 1995. PMID: 7602352 Clinical Trial.
121 results